Lorlatinib/lorlatinib side effects

Lorlatinib/Lorlatinib is a multikinase inhibitor that is used to treat patients with a certain type of ALK mutation that has spread to other parts of the body. Kinase inhibitors are enzyme inhibitors that block the action of protein kinases. Lorlatinib/What are the side effects of lorlatinib?

lorlatinib/lorlatinibThe most common (20%or more)adverse reactions are edema, peripheral neuropathy, cognitive effects, dyspnea, cough, fatigue, weight gain, joint pain, mood effects, and diarrhea. The most common(20%or more)laboratory abnormalities are hypercholesterolemia, hypertriglyceridemia, anemia, hyperglycemia, ASTelevated, hypoalbuminemia, ALTelevated, lipase elevated and alkaline phosphatase elevated.

Lorlatinib/Lorlatinib is a potent brain-penetrating third-generation ALK and ROS1 tyrosine kinase inhibitor that broadly covers ALK mutations. Lorlatinibin patients receiving treatment for the first timeALKpositive non-small cell lung cancer, and in patients receiving crizotinib(second-generationALKTyrosine kinase inhibitors) showed significant overall and intracranial activity in patients who had progressed or after prior use of up to three ALK tyrosine kinase inhibitors. Therefore, lorlatinib may be an effective treatment option for patients with ALK-positive NSCLC in the first-line or follow-up setting. Lorlatinib has been launched at home and abroad. The price of foreign generic drugs is favorable, ranging from 3 to 5 thousand per box. If you want to get more quality information, you can contact MedicineDe, YaoDe will do its best to learn more about high-quality overseas drugs for you.